Medindia

X

CorVel Announces Revenues and Earnings

Tuesday, August 3, 2010 Corporate News J E 4
Advertisement


IRVINE, Calif., Aug. 3 CorVel Corporation (Nasdaq: CRVL) reported earnings per share of $0.64 for the quarter ended June 30, 2010, a 30% increase compared to $0.49 in the same quarter of the prior fiscal year. The Company reported quarterly revenues of $91.5 million, a 13% increase compared to $81.3 million in the same quarter of the prior fiscal year.

Revenue growth compared to the same quarter the prior year was lead by a 31% increase in the Company's Patient Management product line which includes traditional case management services and claims management. Claims management growth included additional new customers and the improved integration of CorVel service components. CorVel's claims management program continues to gain momentum in the market place. The Company has increased its information technology resourcing in order to advance the pace of delivery of new features for clients. CorVel seeks to improve claims outcomes through such investments. These technology projects will incorporate artificial intelligence to improve the Company's managed workflow environment.

Network Solutions revenue was flat compared to the same quarter last year. Growth in the Company's pharmacy solutions and directed care networks offset a slight decline in medical bill review revenues.

About CorVel

CorVel Corporation is a national provider of leading-edge services and solutions in the field of disability management. CorVel specializes in applying information technology and e-commerce applications to improve outcomes in the workers' compensation, group health, auto and disability management insurance markets. The Company provides claims management solutions in addition to networks of preferred providers, case management, utilization management and medical bill review to more than 2,000 clients nationwide. Leveraging its commitment to flexibility and personal service, CorVel delivers custom solutions for employers, insurers, third party administrators and government entities.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

All statements included in this press release, other than statements or characterizations of historical fact, are forward-looking statements. These forward-looking statements are based on the Company's current expectations, estimates and projections about the Company, management's beliefs, and certain assumptions made by the Company, and events beyond the Company's control, all of which are subject to change. Such forward-looking statements include, but are not limited to, statements relating to the Company's results of operations, product investment strategies and expansion of directed care solutions. These forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause the Company's actual results to differ materially and adversely from those expressed in any forward-looking statement.

The risks and uncertainties referred to above include, but are not limited to, factors described in this press release and the Company's filings with the Securities and Exchange Commission, including but not limited to "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended March 31, 2010. The forward-looking statements in this press release speak only as of the date they are made. The Company undertakes no obligation to revise or update publicly any forward-looking statement for any reason.

CorVel Corporation Quarterly Results -Income Statement Quarters Ended June 30, 2009 and 2010 (unaudited)

SOURCE CorVel Corporation
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
DUSA Pharmaceuticals Reports Second Quarter 2010 C...
S
Cord Blood America Says U.S., Worldwide Research S...